Beijing Gene+ Technology
Beijing Gene+, also known as Beijing Gene Plus, provides gene testing services for cancer prevention.
Launch date
Employees
Market cap
-
Enterprise valuation
€422—633m (Dealroom.co estimates Jul 2021.)
Beijing China (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$30.0m | Series A | ||
| N/A | CNY50.0m | Series B | |
| N/A | $28.0m | Series B | |
$38.0m | Series B | ||
$116m | Series C | ||
| Total Funding | €199m | ||
Related Content
Recent News about Beijing Gene+ Technology
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.